Product NDC: | 0409-5820 |
Proprietary Name: | DOPamine Hydrochloride |
Non Proprietary Name: | Dopamine Hydrochloride |
Active Ingredient(s): | 40 mg/mL & nbsp; Dopamine Hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION, CONCENTRATE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-5820 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018132 |
Marketing Category: | NDA |
Start Marketing Date: | 20110726 |
Package NDC: | 0409-5820-01 |
Package Description: | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-5820-01) > 5 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 0409-5820-01 |
Proprietary Name | DOPamine Hydrochloride |
Package Description | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-5820-01) > 5 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 0409-5820 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Dopamine Hydrochloride |
Dosage Form Name | INJECTION, SOLUTION, CONCENTRATE |
Route Name | INTRAVENOUS |
Start Marketing Date | 20110726 |
Marketing Category Name | NDA |
Labeler Name | Hospira, Inc. |
Substance Name | DOPAMINE HYDROCHLORIDE |
Strength Number | 40 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Catecholamine [EPC],Catecholamines [Chemical/Ingredient] |